Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 19,765 full-time employees. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenue
2,052,148
1,886,256
1,601,688
1,278,478
1,044,892
962,516
Revenue Growth (YoY)
14%
18%
25%
22%
9%
-2%
Cost of Revenue
460,944
415,797
415,322
363,525
353,328
338,289
Gross Profit
1,591,204
1,470,459
1,186,366
914,953
691,564
624,227
Selling, General & Admin
805,873
731,200
636,997
471,221
358,309
333,079
Research & Development
473,098
435,965
365,169
341,570
260,228
227,353
Operating Expenses
1,273,815
1,138,534
974,778
794,373
618,539
560,432
Other Non Operating Income (Expenses)
0
838
-1,347
-197
-1,233
4,537
Pretax Income
350,581
355,631
237,234
126,854
73,516
74,124
Income Tax Expense
45,981
63,017
34,403
17,902
6,521
-1,526
Net Income
304,599
295,756
200,731
109,188
66,972
75,958
Net Income Growth
24%
47%
84%
63%
-12%
-41%
Shares Outstanding (Diluted)
1,851.04
1,897.45
1,918.65
1,918.58
1,918.49
1,941.97
Shares Change (YoY)
-2%
-1%
0%
0%
-1%
0%
EPS (Diluted)
164.55
155.86
104.62
56.91
34.92
39.11
EPS Growth
27%
49%
84%
63%
-11%
-41%
Free Cash Flow
-53,335
-134,030
467,245
47,148
62,544
128,114
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
77.53%
77.95%
74.06%
71.56%
66.18%
64.85%
Operating Margin
15.46%
17.59%
13.21%
9.43%
6.98%
6.62%
Profit Margin
14.84%
15.67%
12.53%
8.54%
6.4%
7.89%
Free Cash Flow Margin
-2.59%
-7.1%
29.17%
3.68%
5.98%
13.31%
EBITDA
391,706
400,574
271,234
188,369
131,270
121,177
EBITDA Margin
19.08%
21.23%
16.93%
14.73%
12.56%
12.58%
D&A For EBITDA
74,317
68,649
59,646
67,789
58,245
57,382
EBIT
317,389
331,925
211,588
120,580
73,025
63,795
EBIT Margin
15.46%
17.59%
13.21%
9.43%
6.98%
6.62%
Effective Tax Rate
13.11%
17.71%
14.5%
14.11%
8.87%
-2.05%
Follow-Up Questions
What are Daiichi Sankyo Company, Limited's key financial statements?
According to the latest financial statement (Form-10K), Daiichi Sankyo Company, Limited has a total asset of $3,456,119, Net profit of $295,756
What are the key financial ratios for DSNKY?
Daiichi Sankyo Company, Limited's Current ratio is 1.88, has a Net margin is 15.67, sales per share of $994.09.
How is Daiichi Sankyo Company, Limited's revenue broken down by segment or geography?
Daiichi Sankyo Company, Limited largest revenue segment is Other, at a revenue of 2,695,000,000 in the most earnings release.For geography, Japan is the primary market for Daiichi Sankyo Company, Limited, at a revenue of 583,802,000,000.
Is Daiichi Sankyo Company, Limited profitable?
yes, according to the latest financial statements, Daiichi Sankyo Company, Limited has a net profit of $295,756
Does Daiichi Sankyo Company, Limited have any liabilities?
yes, Daiichi Sankyo Company, Limited has liability of 1,832,703
How many outstanding shares for Daiichi Sankyo Company, Limited?
Daiichi Sankyo Company, Limited has a total outstanding shares of 1,866.65